IDEAYA Biosciences (NASDAQ:IDYA) said Monday it has priced an underwritten public offering of shares and warrants to raise about $263 million. The company plans to offer 7.3 million shares of common stock at $35 per share and pre-funded warrants to purchase 285,715 shares of common stock at $34.9999 a piece.Continue Reading
xbrchx/iStock via Getty Images MarineMax (NYSE:HZO) rose 4% in after hours trading after Island Capital Group offered to buy a 100% interest in the company’s yachting and marina business. Island Capital Group, which is run by Andrew L. Farkas, who sold the YRMS business to MarineMax (HZO) in 2022 forContinue Reading
Sundry Photography/iStock Editorial via Getty Images HashiCorp (NASDAQ:HCP) edged lowed by almost 1% amid some investor concern that its planned sale to IBM (NYSE:IBM) will get a request for more information from antitrust regulators. Investors are worried that the Federal Trade Commission will issue a second request as a FridayContinue Reading
baileystock Tesla Inc. (NASDAQ:TSLA) is “acting like a meme stock,” said investor and fund manager Bill Gross, in an X post. The American investor and co-founder of PIMCO tweeted that Tesla (TSLA) has “sagging fundamentals, and straight up price action.” The stock is up about 6% year-to-date, but went upContinue Reading
Dmitry Vinogradov Multiple bullish initiations on Tempus AI (NASDAQ:TEM) failed to impress Wall Street as the AI-driven life sciences firm traded lower on Tuesday, extending a recent selloff that followed its public debut last month. Since its IPO in mid-June, SoftBank (OTCPK:SFTBY) (OTCPK:SFTBF)-backed Tempus (TEM) has lost nearly 20%, aContinue Reading
Assured Guaranty stock (NYSE:AGO) rose 3.78% after brokerage firm KBW upgraded it to Outperform from Market perform, citing that the company’s valuation at 0.70x year-end book looks very compelling. The stock was trading at $79.60 in the morning on Tuesday. AGO had risen 41.16% in the last 12 months. TheContinue Reading
Maksim Labkouski Shares of ReShape Lifesciences (NASDAQ:RSLS) climbed in the premarket Tuesday after the medical device maker reached a merger agreement to combine with privately held specialty pharma company Vyome Therapeutics in an all-stock transaction. Per the terms of the deal, current ReShape (RSLS) stockholders will own a roughly 11.1%Continue Reading
MicroStockHub U.K.-listed shares of Indivior (NASDAQ:INDV) lost more than a third on Tuesday after the pharma company lowered its FY 2024 financial outlook, citing, among other things, sales headwinds related to Sublocade, a prescription drug indicated for opioid use disorder. Indivior (INDV), based in North Chesterfield, Virginia, also announced aContinue Reading
Artur Plawgo uniQure (NASDAQ:QURE) shares traded higher premarket Tuesday after the Dutch biotech posted the latest data from its Phase 1/2 clinical trials for AMT-130, an investigational gene therapy for Huntington’s disease, a rare, inherited neurodegenerative disorder. Based on a Mar. 31 data cut of 21 patients, the company saidContinue Reading
fredrocko BP (NYSE:BP) expects to book impairment charges of $1B-$2B for Q2, and warned of weak oil trading earnings amid “significantly lower” refining margins, sending its shares falling 3.8% in premarket trade on Tuesday. The after-tax asset impairments and one-off contract provisions include charges relating to the ongoing review ofContinue Reading
